22.418 articles found

Should the injured and intact hemispheres be treated differently during the early phases of physical restorative therapy in experimental stroke or parkinsonism?

Schallert T, Fleming SM, Woodlee MT.

Phys Med Rehabil Clin N Am · 2003-02-01

DOI: 10.1016/s1047-9651(02)00055-4PMID: 12625636

Diagnosis and treatment of enteric neuromuscular diseases.

Camilleri M.

Clin Auton Res · 2003-02-01

DOI: 10.1007/s10286-003-0073-yPMID: 12664242

Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics.

Pong K.

Expert Opin Biol Ther · 2003-02-01

DOI: 10.1517/14712598.3.1.127PMID: 12718737

Pharmacotherapy of behavioral and psychological symptoms of dementia: a review of atypical antipsychotics.

Daiello LA, Beier MT, Hoffmann VP, Kennedy JS.

Consult Pharm · 2003-02-01

PMID: 16563055

Therapeutic agents useful for treating pain

KYLE DONALD J, QUN SUN.

· 2003-01-31

A2A receptor antogonists for use in the treatment of movement disorders

KASE HIROSHI, MORI AKIHISA, WAKI YUTAKA, OHSAWA YUTAKA, KARASAWA AKIRA, KUWANA YOSHIHISA.

· 2003-01-28

Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal

COE JOTHAM WADSWORTH, SANDS STEVEN BRADLEY, HARRIGAN EDMUND PATRICK, O'NEILL BRIAN THOMAS, WATSKY ERIC JACOB.

· 2003-01-21

Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease

SOARES DA SILVA PATRICIO.

· 2003-01-08

The feasibility of using brief cognitive behavioural therapy for depression associated with Parkinson's disease

Cole K.

· 2003-01-01

Striatal and extra-striatal dopaminergic function in Parkinson's disease and the effect of dopamine agonist therapy on PD progression studies with 3D[¹⁸F]-dopa PET

Rakshi J.

· 2003-01-01

The role of the metabotropic GabaB receptor in the rodent basal ganglia and its potential as a therapeutic target in Parkinson's disease

Johnston TH.

· 2003-01-01

The role of group II and III metabotropc glutamate receptors in the basal ganglia and their potential as a treatment target for Parkinson's disease

Messenger MJ.

· 2003-01-01